The most common type of this cancer is osteosarcoma, also known as osteogenic sarcoma. This cancer typically develops near ...
The US FDA granted OST-HER2 rare pediatric disease designation for osteosarcoma in 2021. The US FDA rare pediatric disease PRV program aims to incentivize drug development for rare pediatric diseases.